HSAC2 receives redemption requests for 1.6M shares ahead of Jan 24 merger vote

Orchestra BioMed Holdings, Inc.

As of Jan 23, 2023, 1,597,888 ordinary shares tendered for redemption by shareholders.
Extraordinary general meeting scheduled for Jan 24, 2023 to vote on business combination with Orchestra BioMed.
Redemption requests relate to pro rata portion of trust account from HSAC2's IPO; exact trust value not disclosed.
Shareholders may still redeem shares up to the vote; final redemption count may change.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.